Other languages Seegene, Inc.

Equities

A096530

KR7096530001

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
21,900 ^KRW	-1.35%		+1.86%	-4.37%

Mar. 14	Seegene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 24	Seegene Inc. Announces Collaboration with Microsoft to Realize a World Free from All Diseases	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Seegene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14
Seegene Inc. Announces Collaboration with Microsoft to Realize a World Free from All Diseases	Jan. 24
Seegene, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
Seegene, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Seegene Inc. Unveils Solutions to Popularize Molecular Diagnostics At 2023 AACC	23-07-31
Seegene, Inc. announces an Equity Buyback for KRW 30,000 million worth of its shares.	23-07-12
Seegene, Inc. authorizes a Buyback Plan.	23-07-12
Seegene, Inc. and Werfen Partner to Collaborate on Onesystem Business to Develop Syndromic qPCR Assays	23-06-14
Seegene and Werfen Partner to Collaborate on OneSystem(TM) Business to Develop Syndromic qPCR Assays	23-06-14
Seegene, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
Seegene, Inc. announces an Equity Buyback for KRW 50,000 million worth of its shares.	23-02-28
Seegene, Inc. authorizes a Buyback Plan.	23-02-27
Seegene, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14
Seegene, Inc. announces an Equity Buyback for KRW 50,000 million worth of its shares.	22-09-28
Seegene, Inc. authorizes a Buyback Plan.	22-09-27
Seegene, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-16
Seegene, Inc. to Pave Way for PCR Testing At Local Clinics with EU-Approved Multiplex Test and Fully Automated PCR Solution	22-06-29
Seegene Obtains EU Approval for its Allplex SARS-CoV-2/FluA/FluB/RSV Assay	22-06-29
Seegene Inc. Develops PCR Test to Detect Monkeypox Virus	22-06-28
Seegene, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Seegene, Inc.

Equities

A096530

KR7096530001

Other languages

Filters